The present study determined the thyroid hormone interference of tetrabromobisphenol A (TBBPA) in Sprague-Dawley (SD) rats, and the derived-reference dose (RfD) of different endpoint effects on mammals based on ...The present study determined the thyroid hormone interference of tetrabromobisphenol A (TBBPA) in Sprague-Dawley (SD) rats, and the derived-reference dose (RfD) of different endpoint effects on mammals based on experimental results and data collection. Based on repeated exposure toxicity tests on mammals and extensive research, the present study used BMDS240 Software to derive a benchmark dose, and analyzed the accuracy and uncertainty, and similarity with other studies. Test results on triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH) demonstrated that all the indicators presented a non-monotonous dose-effect relationship clearly, except TSH in male rats exposed to 0-1000 mg/kg BW per day. Therefore, RfDs were derived from different critical effects. In summary, RfD for mammals in the present study was found to be 0.6 mg/kg per day.展开更多
Objective:To investigate the effect of Xin-Nao-Xue-Mai-Ning(XNXMN)on hypothyroidism in SD rats and explore the effect of IRE1-XBP1 signaling pathway on hypothyroidism in rats,and to analyze the possible mechanism of X...Objective:To investigate the effect of Xin-Nao-Xue-Mai-Ning(XNXMN)on hypothyroidism in SD rats and explore the effect of IRE1-XBP1 signaling pathway on hypothyroidism in rats,and to analyze the possible mechanism of XNXMN in the treatment of hypothyroidism.Method:Twenty-four male SD rats were given a 0.1%concentration of propylthiouracil(PTU)solution by gavage every day to establish a hypothyroidism animal model.After the completion of the model building,intervention with XNXMN.Observe the general conditions of rats,serum triiodothyronine(T3),tetraiodothyronine(T4),thyroid stimulating hormone(TSH)levels,X box binding protein 1(XBP-1)protein expression level,and perform statistical analysis.Results:XNXMN can improve the general condition of hypothyroidism rats,reduce serum TSH,increase T3,T4 and reduce the expression of XBP1 protein in thyroid endoplasmic reticulum.Conclusion:XNXMN can improve the symptoms of hypothyroidism rats and has the effect of treating hypothyroidism.Its mechanism of action may be related to the expression of IRE1-XBP1 signaling pathway proteins that regulate the unfolded protein pathway of the endoplasmic reticulum.展开更多
基金supported by the National Natural Science Foundation of China(No.21377045)Joint Innovation Funding of Production and Research-a Prospective Joint Research Project(BY2015027-05)
文摘The present study determined the thyroid hormone interference of tetrabromobisphenol A (TBBPA) in Sprague-Dawley (SD) rats, and the derived-reference dose (RfD) of different endpoint effects on mammals based on experimental results and data collection. Based on repeated exposure toxicity tests on mammals and extensive research, the present study used BMDS240 Software to derive a benchmark dose, and analyzed the accuracy and uncertainty, and similarity with other studies. Test results on triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH) demonstrated that all the indicators presented a non-monotonous dose-effect relationship clearly, except TSH in male rats exposed to 0-1000 mg/kg BW per day. Therefore, RfDs were derived from different critical effects. In summary, RfD for mammals in the present study was found to be 0.6 mg/kg per day.
基金This research was supported by the Tianjin Health Commission,Tianjin Administration of Traditional Chinese Medicine-Traditional Chinese Medicine,and Integrated Traditional Chinese and Western Medicine Scientific Research Projects(No.2019036).
文摘Objective:To investigate the effect of Xin-Nao-Xue-Mai-Ning(XNXMN)on hypothyroidism in SD rats and explore the effect of IRE1-XBP1 signaling pathway on hypothyroidism in rats,and to analyze the possible mechanism of XNXMN in the treatment of hypothyroidism.Method:Twenty-four male SD rats were given a 0.1%concentration of propylthiouracil(PTU)solution by gavage every day to establish a hypothyroidism animal model.After the completion of the model building,intervention with XNXMN.Observe the general conditions of rats,serum triiodothyronine(T3),tetraiodothyronine(T4),thyroid stimulating hormone(TSH)levels,X box binding protein 1(XBP-1)protein expression level,and perform statistical analysis.Results:XNXMN can improve the general condition of hypothyroidism rats,reduce serum TSH,increase T3,T4 and reduce the expression of XBP1 protein in thyroid endoplasmic reticulum.Conclusion:XNXMN can improve the symptoms of hypothyroidism rats and has the effect of treating hypothyroidism.Its mechanism of action may be related to the expression of IRE1-XBP1 signaling pathway proteins that regulate the unfolded protein pathway of the endoplasmic reticulum.